877
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B

, , , , , , & show all
Pages 755-760 | Received 28 Aug 2018, Accepted 06 Nov 2018, Published online: 04 Dec 2018

Figures & data

Figure 1. Analysis of purified recombinant BHc protein during various purification steps by SDS-PAGE and western bolt. The soluble fraction and purified BHc were subjected to 10% SDS-PAGE and Western blot analysis using hyperimmune anti-neurotoxin B serum. Lane 1, pTIG-Trx vector transformed cell lysates; Lane 2, pTIG-Trx-BHc transformed BL21 cell lysates; Lane 3, MMC column purified products; Lane 4, Source 30s column purified products; Lane 5, Western blot analysis; M, protein markers 180, 130, 95, 72(red), 55, 43, 34, 26 and 17 KDa (from top to bottom); An arrow indicates the position of the BHc.

Figure 1. Analysis of purified recombinant BHc protein during various purification steps by SDS-PAGE and western bolt. The soluble fraction and purified BHc were subjected to 10% SDS-PAGE and Western blot analysis using hyperimmune anti-neurotoxin B serum. Lane 1, pTIG-Trx vector transformed cell lysates; Lane 2, pTIG-Trx-BHc transformed BL21 cell lysates; Lane 3, MMC column purified products; Lane 4, Source 30s column purified products; Lane 5, Western blot analysis; M, protein markers 180, 130, 95, 72(red), 55, 43, 34, 26 and 17 KDa (from top to bottom); An arrow indicates the position of the BHc.

Table 1. Survival, group antibody ELISA titers, and serum neutralization titers of mice after vaccination with BHc and mBHC antigens.

Table 2. Survival, group antibody ELISA titers, and serum neutralization titers of mice after vaccination with BHc vaccine.

Figure 2. Survival of mice immunized with BHc vaccine. Mice alive after challenge with a dose of 1000 LD50 of BoNT/B 3 weeks after one injection or 10,000LD50 of BoNT/B 3 weeks after two injections.

Figure 2. Survival of mice immunized with BHc vaccine. Mice alive after challenge with a dose of 1000 LD50 of BoNT/B 3 weeks after one injection or 10,000LD50 of BoNT/B 3 weeks after two injections.

Figure 3. Anti-BHc antibody titers in mice vaccinated with one or two doses of BHc formulated with aluminum hydroxide adjuvant. Mice were immunized one or two doses with 0.039 μg to 4 μg of BHc formulated with aluminum hydroxide adjuvant. Sera form individual mice from each group (n = 5) three weeks after final immunization were collected and specific antibody titer were analyzed by ELISA. Serum sample from individual mice sere assayed and the geometric mean titer (GMT) was calculated for each group.

Figure 3. Anti-BHc antibody titers in mice vaccinated with one or two doses of BHc formulated with aluminum hydroxide adjuvant. Mice were immunized one or two doses with 0.039 μg to 4 μg of BHc formulated with aluminum hydroxide adjuvant. Sera form individual mice from each group (n = 5) three weeks after final immunization were collected and specific antibody titer were analyzed by ELISA. Serum sample from individual mice sere assayed and the geometric mean titer (GMT) was calculated for each group.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.